Al­aba­ma set­tles for $276M with McKesson, J&J and En­do over opi­oid cri­sis

Al­aba­ma’s at­tor­ney gen­er­al stood by his de­ci­sion to not par­tic­i­pate in the na­tion­al opi­oid set­tle­ments, an­nounc­ing Tues­day that the state has reached deals with John­son & John­son, En­do Phar­ma­ceu­ti­cals and McKesson for about $276 mil­lion to re­solve the state’s claims against them for ex­ac­er­bat­ing the opi­oid cri­sis.

J&J will pay about $70 mil­lion in a lump-sum pay­ment, which is the same amount as what Al­aba­ma would’ve re­ceived in a na­tion­al set­tle­ment, but it’ll be paid out in one year in­stead of 9 years, the AG said. J&J al­so re­cent­ly agreed to pay West Vir­ginia $99 mil­lion as part of an­oth­er opi­oid-re­lat­ed set­tle­ment.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.